192 related articles for article (PubMed ID: 10233942)
1. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.
Crawford SE; Estes MK; Ciarlet M; Barone C; O'Neal CM; Cohen J; Conner ME
J Virol; 1999 Jun; 73(6):4813-22. PubMed ID: 10233942
[TBL] [Abstract][Full Text] [Related]
2. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.
Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME
Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709
[TBL] [Abstract][Full Text] [Related]
3. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.
Ciarlet M; Crawford SE; Barone C; Bertolotti-Ciarlet A; Ramig RF; Estes MK; Conner ME
J Virol; 1998 Nov; 72(11):9233-46. PubMed ID: 9765471
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.
Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK
Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus subunit vaccines.
Conner ME; Crawford SE; Barone C; O'Neal C; Zhou YJ; Fernandez F; Parwani A; Saif LJ; Cohen J; Estes MK
Arch Virol Suppl; 1996; 12():199-206. PubMed ID: 9015116
[TBL] [Abstract][Full Text] [Related]
6. Virus-like particles as a rotavirus subunit vaccine.
Conner ME; Zarley CD; Hu B; Parsons S; Drabinski D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Madore HP; Crawford S; Estes MK
J Infect Dis; 1996 Sep; 174 Suppl 1():S88-92. PubMed ID: 8752296
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine.
Madore HP; Estes MK; Zarley CD; Hu B; Parsons S; Digravio D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Crawford S; Conner ME
Vaccine; 1999 May; 17(19):2461-71. PubMed ID: 10392629
[TBL] [Abstract][Full Text] [Related]
8. Homotypic and heterotypic immune responses to group A rotaviruses in parenterally immunized sheep.
Beards GM; King JA; Mazhar S; Landon J; Desselberger U
Vaccine; 1993; 11(2):262-6. PubMed ID: 8382420
[TBL] [Abstract][Full Text] [Related]
9. Cross-neutralizing antibodies induced by single serotype vaccination of cows with rotavirus.
Brüssow H; Walther I; Fryder V; Sidoti J; Bruttin A
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1647-58. PubMed ID: 2839600
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus vaccine administered parenterally induces protective immunity.
Conner ME; Crawford SE; Barone C; Estes MK
J Virol; 1993 Nov; 67(11):6633-41. PubMed ID: 8411366
[TBL] [Abstract][Full Text] [Related]
11. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.
Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB
J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654
[TBL] [Abstract][Full Text] [Related]
12. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
Gorrell RJ; Bishop RF
J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
[TBL] [Abstract][Full Text] [Related]
13. Serologic and mucosal immune response to rotavirus infection in the rabbit model.
Conner ME; Gilger MA; Estes MK; Graham DY
J Virol; 1991 May; 65(5):2562-71. PubMed ID: 1850029
[TBL] [Abstract][Full Text] [Related]
14. Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development.
Green KY; Taniguchi K; Mackow ER; Kapikian AZ
J Infect Dis; 1990 Apr; 161(4):667-79. PubMed ID: 2156942
[TBL] [Abstract][Full Text] [Related]
15. Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.
Offit PA; Clark HF; Blavat G; Greenberg HB
J Virol; 1986 Nov; 60(2):491-6. PubMed ID: 3021983
[TBL] [Abstract][Full Text] [Related]
16. Rotavirus virus-like particles administered mucosally induce protective immunity.
O'Neal CM; Crawford SE; Estes MK; Conner ME
J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
[TBL] [Abstract][Full Text] [Related]
17. Analysis of host range restriction determinants in the rabbit model: comparison of homologous and heterologous rotavirus infections.
Ciarlet M; Estes MK; Barone C; Ramig RF; Conner ME
J Virol; 1998 Mar; 72(3):2341-51. PubMed ID: 9499095
[TBL] [Abstract][Full Text] [Related]
18. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
19. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
20. Rotaviruses: immunological determinants of protection against infection and disease.
Offit PA
Adv Virus Res; 1994; 44():161-202. PubMed ID: 7817873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
